Since the majority (60 to 70%) of patients that are diagnosed with NMO according to clinical criteria are positive for anti-AQP4 antibodies of the IgG1 isotype [2], [11], [12], the presence of NMO-IgG has been incorporated in the diagnostic criteria for NMO [13]. Here, AQP4 is linked to neuromyelitis optica.